Form 4 for ACRS Aclaris Therapeutics, Inc.
Accepted 2023-09-07 00:00:00 ET · period of report 2023-09-06 · accession 0001209191-23-048612 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-07 | 2023-09-06 | ACRS | Balthaser Kevin | CFO | P - Purchase | $7.90 | +9,490 | 15.5K | +159% | +$75.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-06 | P | A | 9,490 | $7.90 | 15,461 | D | — | — |